Abstract
Anti-α-galactosyl (anti-Gal) is a human natural antibody which constitutes as much as 1% of circulating IgG and which interacts specifically with the carbohydrate epitope Galα 1–3 Galβ1– 4GlcNac-R (termed the α-gal epitope). This natural antibody is unique among known human natural antibodies because of its unusually high concentration in the serum (30–100 μg/ ml)( Avila et al., 1989; Davin et al., 1987; Galili et al., 1984), and is presence in all humans (Galili et al., 1984). The only other mammals producing anti-Gal are Old World monkeys and apes (Galili et al., 1987b).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Almeida, I.C., Milani, S.R., Gorin, P.A.J., and Travassos, L.R., 1991, Complement mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-α-galactosyl antibodies. J. Immunol. 146: 2394–2400.
Almeida, I.C., Krautz, G.M., Krettli, A.U., and Travassos, L.R., 1993, Glycoconjugates of Trypanosoma cruzi: A 74 Kd antigen of trypomastigotes specifically reacts with lytic anti-α-galactosyl antibodies from patients with chronic Chagas disease. J. Clin. Laborat. Anal. 7: 307–316.
Almeida, I.C., Ferguson M.A., Schenkman, S., and Travassos, L., 1994, Lytic anti-α-galactosyl antibodies from patients with chronic Chagas’ disease recognize novel O-linked oligosaccharides on mucin-like glycosylphosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem. J. 304: 793–802.
Alvarado, C.G., Cotterell, A.H., McCurry, K.R., Collins, B.H., Magee, J.C., Berthold, J., Logan, J.S., and Platt, J.L., 1995, Variation in the level of xenoantigen expression in porcine organs. Transplantation 59: 1589–1594.
Andrade, Z., 1985, A patologia da doença de Chagas no homen. Ann. Soc. Belg. Med. Trop. 65 (Suppl 1): 15–30.
Andrade, S.G., and Grimaud, J.A., 1986, Chronic murine myocarditis due to Trypanosoma cruzi-an structural study and immunochemical characterization of cardiac interstitial matrix. Mem. Inst. Oswaldo Cruz 81: 29–41.
Andrade, S.G., Grimaud, J.A., and Stocker-Guerret, S., 1989, Sequential changes of the connective matrix components of the myocardium (fibronectin and laminin) and evaluation of cardiac fibrosis in mice infected with Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 40: 151–60.
Araujo, M. A., 1989, Lise de Trypanosoma cruzi por soros de pacientes na fase aguda da doenca de Chagas. Ph.D. Thesis, University of Sao Paulo.
Avila, J.L., 1992, Molecular mimicry between Trypanosoma cruzi and host nervous tissues. Acta. Cient. Venez. 43: 330–340.
Avila, J.L., 1993, Glycosyl phosphatidylinositols in Leishmania and Trypanosoma. Trends in Comparat. Biochem. Physiol. 1: 881–906.
Avila, J.L., 1994, Molecular mimicry between Trypanosoma cruzi and host nervous tissues. In: Chagas disease and the nervous system. Pan American Health Organization. Sci. Publ. N° 547, Washington, pp. 268–292.
Avila, J.L., and Rojas, M., 1990, A galactosyl(α1–3)mannose epitope on phospholipids of Leishmania mexicana and L. braziliensis is recognized by trypanosomatid-infected human sera. J. Clin. Microbiol. 28: 1530–1537.
Avila, J.L., Rojas, M., and Reiber, M., 1984, Antibodies to laminin in American cutaneous leishmaniasis. Infect. Immun. 43: 402–406.
Avila, J.L., Rojas, M., and Towbin, H., 1988a, Serological activity against galactosyl-α(1–3)galactose in sera from patients with several kinetoplastida infections. J. Clin. Microbiol. 26: 126–132.
Avila, J.L., Rojas, M., and Garcia, L., 1988b, Persistence of elevated levels of galactosyl-α(1–;3)galactose antibodies in sera from patients cured of visceral leishmaniasis. J. Clin.Microbiol. 26: 1842–1847.
Avila, J.L., Rojas, M., and Galili, U., 1989, Immunogenic Galα 1–3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania. J. Immunol. 142: 2828–2834.
Avila, J.L., Rojas, M., and Acosta, A., 1991, Glycoinositol phospholipids from American Leishmania and Trypanosoma spp.: Partial characterization of the glycan cores and the human humoral immune response to them. J. Clin. Microbiol. 29: 2305–2312.
Avila, J.L., Rojas, M., and Velasquez-Avila, G., 1992, Characterization of a natural human antibody with anti-galactosyl(α1–2)galactose specificity that is present at high titers in chronic Trypanosoma cruzi infection. Am. J. Trop. Med, Hyg. 47: 413–421.
Avila, J.L., Rojas, M., and Avila, A., 1996, Cholesterol sulphate-reactive autoantibodies are specifically increased in chronic chagasic human patients. Clin. Exp. Immunol. 103: 40–46.
Avila, J.L., Rojas, M., and Avila, A., 1998, Increase in asialoganglioside-and monosialoganglioside-reactive antibodies in chronic Chagas’ disease patients. Am J. Trop. Med. Hyg. 58: 338–342.
Avila. J.L., Rojas. M., Velazquez-Avila. G., Von Der Mark. H., and Timpl., R., 1986. Antibodies to basement membrane protein nidogen in Chagas’ disease and American cutaneous leishmaniasis. J. Clin. Microbiol. 24: 775–778.
Avila, J.L., Rojas. M., Velazquez-Avila. G., and Rieber. M., 1987, Antibodies to laminin in Trypanosoma rangeli-intected subjects. Parasitol. Res. 73: 178–179.
Bretana, A., Avila, J.L., Arias-Flores, M., Contreras, M., and Tapia F.J., 1986. Trypanosoma cruzi and American Leishmania spp.: immunocytochemical localization of a laminin-like protein in the plasma membrane. Exp. Parasitol. 61: 168–175.
Bretana, A., Avila, J.L., Contreras-Bretana. M., and Tapia, F., 1992. American Leishmania spp. and Trypanosoma cruzi: Galactosylα(1–3)galactose epitope localization by colloidal gold immuno-cytochemistry and lectin cytochemistry. Exp. Parasitol. 74: 27–37.
Carrasco. H.A., Barboza. J.S., Inglessis. G., Fuenmayor. A., and Molina. C. 1982, Left ventricular cineangiography in Chagas’ disease: detection of early myocardial damage. Am. Heart J. 104: 595–602.
Carreira, J.C., Jones, C. Wait. R., Previato, J.O., and Mendoncα-Previato, L., 1996. Structural variation in the glycoinositol phospholipids of differente strains of Trypanosoma cruzi. GlycoconjugateJ. 13: 955–966.
Cotterell, A.H., Collins. B.H., Parker. W., Harland. R.C., and Platt, J.L., 1995, The humoral immune response in humans follow ing cross-perfusion of porcine organs. Transplantation 60: 861–864.
Couto, A.S., Goncalves, M.F., Colli. W., and Lederkremer. R.M., 1990, The N-linked carbohydrate chain of the 85 kilodalton glycoprotein from Trypanosoma cruzi trypomastigotes contains sialyl. fucosyl and galactosyl(α1–3)galactose units. Mol. Biochem. Parasitol. 39: 101–108.
Couto. A.S., Lederkremer. R.M. de. Colli. W., and Alves. M.J., 1993, The glycosylphosphatidylinositol anchor of the trypomastigote-specific Tc-85 glycoprotein from Trypanosoma cruzi. Metabolic-labeling and structural studies. Eur.J. Biochem. 217: 597–602.
Cunhα-Neto, E., Duranti. M., Gruber. A., Zingales. B., De Messias, I., Stolf, N., Bellotti. G., Patarroyo. M. E., Pilleggi. F., and Kalil. J., 1995. Autoimmunity in Chagas disease cardiopathy: Biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc. Satl. Acad. Sci. USA. 92: 3541–3545.
Davin, J.C., Malaise, M., Foidart. J.M., and Mahieu. P., 1987. Anti-α-galactosyl antibodies and immune complexes in children with Henoch-Schonlein purpura of IgA nephropathy. Kidney Int. 31: 1132–1139.
Editorial, 1965, New light on Chagas’ disease. Lancet. 1: 1150–1151.
Egge, H., Kordowicz. M., Peter-Katalinic. J., and Hanfland. P., 1985, Immunochemistry of l/i-active oligo-and polyglycosylceramides from rabbit erythrocyte membranes. J. Biol. Chem. 260: 4927–4935.
Ferguson, M.A.J., Homans, S.W., Dwek. R.A., and Rademacher, T.W., 1988, Glycosylphosphatidylinositol moiety that anchors Trypanosoma brucei variant surface glycoprotein to the membrane. Science 239: 753–759.
Ferrans, V.J., Milei, J., Tomita. Y., and Storino. R., 1988, Basement membrane thickening in cardiac myocytes and capillaries in chronic Chagas’ disease. Am. J. Cardiol. 61: 1137–1140.
Galili, U., Rachmilewitz. E. A., Peleg, A., and Flechner. I., 1984. A unique natural human IgG antibody with anti-α-galactosyl specifity. J. Exp. Med. 160: 1519–1531.
Galili, U., Basbaum, C.B., Shohet, S.B., Buehler. J., and Macher. B.A., 1987a. Identification of erythrocyte Galα1–3Gal glycosphingolipids with a mouse monoclonal antibody Gal-13. J. Biol. Chem. 262: 4683–4688.
Galili, U., Clark, M.R., Shohet, S.B., Buehler, J., and Macher, B.A., 1987b, Evolutionary relationship between the anti-Gal antibody and the Galα1–3Gal epitope in primates. Proc. Natl. Acad. Sci. USA 84: 1369–1373.
Gazzinelli, R.T., 1992, Natural anti-Gal antibodies prevent, rather than cause, autoimmunity in human Chagas’ disease. Res. Immunol. (36th Forum in Immunology) 142: 164–167.
Gazzinelli, G., and Brener, Z., 1988, Anti-laminin and specific antibodies in acute Chagas disease. Trans. R. Soc. Trop. Med. Hyg. 82: 574–576.
Gazzinelli, R.T., Galvao, L.M.C., Cardoso, J.R., Cancado, J.R., Kreettli, A.U., Brener, Z., and Gazzinelli, G., 1988, Anti-Trypanosoma cruzi and antilaminin antibodies in chagasic patients after specific treatment. J. Clin. Microbiol. 26: 1795–1800.
Gazzinelli, R.T., Pereira, M.E.S., Romanha, A., Gazzinelli, G., and Brener, Z., 1991a, Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies. Parasite Immunol. 13: 345–356.
Gazzinelli, R.T., Romanha, A.J., Fontes, R., Chiari, E., Gazzinelli, G., and Brener, Z., 1991 b. Distribution of carbohydrates recognized by the lectins Euonymus europaeus and Concanavalin A in monoxenic and heteroxenic trypanosomatids. J. Protozool. 38: 320–325.
Geller, R.L., Rubinstein, P., and Platt, J.L., 1994, Variation in expression of porcine xenogeneic antigens. Transplantation 58: 272–274.
Grauen, MR., Houdayer, M., and Hontebeyrie-Joskowciz, M., 1993, Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas’ disease. Clin. Exp. Immunol. 93: 85–92.
Goin, J.C., Borda, E., Denduchis, B., Milei, J., Storino. R., and Sterin-Borda, L., 1990, Anticuerpos circulantes en pacientes chagásicos con actividad colinérgica que regulan la funcion cardiaca. Medicina (Bs.As) 50: 385–386.
Kierszenbaum, F., 1986, Autoimmunity in Chagas’ disease. The debate goes on. Reply. Parasitol Today 2: 22–23.
Koberle, F., 1968, Chagas’ disease and Chagas’ syndromes: The pathology of American trypanosomiasis. Adv. Parasitol. 6: 63–116.
Krettli, A.U., and Brener, Z., 1976, Protective effects of specific antibodies in Trypanosoma cruzi infection. J. Immunol. 116: 755–760.
Krettli, A.U., and Brener, Z., 1982, Resistance against Trypanosoma cruzi associated to anti-living trypomastigotes antibodies. J. Immunol. 128: 2009–2012.
Krettli, A.U., Weisz-Carrington, P., and Nussenzweig, R.S., 1979, Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis. Clin. Exp. Immunol. 37: 416–423.
Laguens, R.P., Meckert, P.C., and Chambo, J., 1991, Origin and significance of anti-heart and anti-skeletal muscle autoanti-bodies in Chagas’ disease. Res. Immunol. 142: 160–163.
Lederkremer, R.M., Lima, C., Ramirez, M.I., and Casai, O.L., 1990, Structural features of the lipopeptidophosphoglycan from Trypanosoma cruzi common with the glycophosphatidylinositol anchors. Eur. J. Biochem. 192: 337–345.
Limα-Martins, M.V.C., Sánchez, G., Krettli, A.U., and Brener, Z., 1985, Antibody-dependent cell cytotoxicity against Trypanosoma cruzi is only mediated by protective antibodies. Parasite Immunol. 7: 367–370.
McConville, M.J., and Bacic, A., 1989, A family of glycoinositol phospholipids from Leishmania major. Isolation, characterization and antigenicity. J. Biol. Chem. 24: 757–766.
McConville, M.J., Homans, S.W., Thomas-Oates, J.E., Dell, A., and Bacic, A., 1990, Structures of the glycoinositol phospholipids from Leishmania major. A family of novel galactofuranose-containing glycolipids. J. Biol. Chem. 265: 7385–7394.
McConville, M.J., Collidge, T.A.C., Ferguson, M.A.J., and Schneider, P., 1993, The glycoinositol phospholipids of Leishmania mexicana promastigotes. Evidence for the presence of three distinct pathways of glycolipid biosynthesis. J. Biol. Chem. 268: 15595–15604.
McConville. M.J., and Ferguson, M.A.J., 1993, The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem. J. 294: 305–324.
Milani, S.R., and Travassos. L.R., 1988. Anti-α-galactosyl antibodies in chagasic patients. Possible biological significance. Brazil. J. Med. Biol. Res. 21: 1275–1286.
Milani, S.R., Oliveira. T.G., and Travassos. L.R., 1988. Protective effect of lytic human antibodies binding to carbohydrate epitopes against trypomastigote infection in mice. Memorias do Instituto Oswaldo Cruz 82 (Suppl): 142.
Milei, J., and Storino. R., 1987. Laminin in chagasic auto-immunity? (Letter to Editor). Parasitai Today 3: 119.
Milei, J., Storino. R., Fernández-Alonso. G., Beigelman. R., Vanzulli. S., and Ferrans. V.J., 1992. Endomyocardial biopsies in chronic chagasic cardiomyopathy. Cardiology 80: 424–437.
Milei, J., Sánchez. J., Storino, R., Yu. Z.X., Denduchis. B., and Ferrans. V.J., 1993, Antibodies to laminin and immunohistochemical localization of laminin in chronic chagasic cardiomyopathy: a review. Mol. Cell Biochem. 129: 161–170.
Molina. H.A., Milei. J., and Storino. R., 1984. Chronic Chagas myocardiopathy. Demonstration of in vivo immunoglobulins in heart structures by the immunoperoxidase technique. Cardiology 71: 297–306.
Oldstone, M.B.A., 1987. Molecular mimicry and autoimmune diseases. Cell 50: 819–820.
PAHO, Division of Communicable Disease Prevention and Control. Communicable Disease Program. HPC/HCT. 1994, Leishmaniasis in the Americas. Epidemiol Bull. 15:8–11.
Palacios-Pru. E., Carrasco. H., Scorza, C. and Espinoza. R., 1989. Ultrastructural characteristics of different stages of human chagasic myocarditis. Am. J. Trop. Med. Hyg. 41: 29–40.
Paulsson. M., Aumailley. M., Deutzmann. R., Timpl. R., Beck. K., and Engel. J., 1987. Lamininnidogen complex. Extraction with chelating agents and structural characterization. Eur. J. Biochem. 166: 11–19.
Pearson, R.D., and de Queiroz-Sousa. A., 1996. Clinical spectrum of leishmaniasis. Clin Infect. Dis. 22: 1–13.
Petry, K., and Eisen, H., 1989. Chagas’s disease: a model for the study of autoimmune diseases. Parasitai Today 5: 111–116.
Platt, J.L. 1996, The immunological barriers to xenotransplantation. Crit. Rev. Immunol. 16: 331–358.
Platt, J.L., and Holzknecht. Z.E., 1994. Porcine platelet antigens recognized by human xenoreactive natural antibodies. Transplantation 57: 327–329.
Ramasamy, R., and Reese, R.T., 1986, Terminal galactose residues and the antigenicity of Plasmodium falciparum glycoproteins. Mol. Biochem. Parasitol. 19: 91–101.
Ramasamy, R., and Rajakaruna, R., 1997, Association of malaria with inactivation of α-1,3-galactosyl transferase in catarrhines. Biochim. Biophys. Acta 1360: 241–246.
Salma, N., and Avila, J.L., 1991, Interaction between various strains of T. cruzi and cardiac primary cultures. Acta Cient. Venez. 42: 185.
Sánchez. J.A., Milei. J., Yu. Z.X., Storino. R., Wenthold. R. Jr., and Ferrans, V.J., 1993. Immunohistochemical localization of laminin in the heart of patients with chronic chagasic cardiomyopathy: Relationship to thickening of basement membranes. Amer. Heart J. 126: 1392–1401.
Schwimmbeck, P.L., Yu. D.T. Y., and Oldstone. M.B. A., 1987, Autoantibodies to HLA-B27 in the sera of HLA-27 patients with ankylosing spondylitis and Reiter’s syndrome: Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J. Exp. Med. 166: 173–181.
Schwimmbeck, P.L., Dyrberg, T., Drachman, D., and Oldstone. M.B. A., 1989, Molecular mimicry and myasthenia gravis: Uncovering a novel site of the acetylcholine receptor that has biologicactivity and reacts immunochemically with herpes simplex virus. J. Clin. Invest. 84: 1174–1180.
Schmunis, G.A., 1987, Autoimmunity in Chagas’ disease. Mem. Inst. Oswaldo Cruz 82: 288–310.
Souto-Padron, T., Almeida, I.C., De Souza, W., and Travassos, L.R., 1994, Distribution of α-galactosyl-containing epitopes on Trypanosoma cruzi trypomastigote and amastigote forms from infected Vero cells detected by chagasic antibodies. J. Euk. Microbiol. 41: 47–54.
Souza, M.C., Reis, A.P., Días da Silva, W., and Brener, Z., 1974, Mechanism of acquired immunity induced by Leptomonas pessoai against Trypanosoma cruzi in mice. J. Protozool. 21: 579–584.
Springer, G.F., and Horton, R.F., 1969, Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J. Clin. Invest. 48: 1280–1291.
Stefani, M.M.A., Oliveira, E.B., Luquetti, A.O., and Dias Da Silva, W., 1987, Complement independent lysis of Trypanosoma cruzi Y strain by sera from acute phase chagasic patients. C-reactive protein and protein involvement. Memorias do Instituto Oswaldo Cruz 82 (Suppl): 140.
Szarfman, A., Terranova, V.P., Rennard, S.I., Foidart, J.M., De Fatima Lima, M., Scheinman, J.I., and Martin, G.R., 1982, Antibodies to laminin in Chagas’ disease. J. Exp. Med. 155: 1161–1171.
Takehara, H.A., Perini, A., Da Silva, M.H., and Mota, I., 1981. Trypanosoma cruzi: role of different antibody classes in protection against infection in the mouse. Exp. Parasitai. 52: 137–146.
Takeuchi, Y., Porter, C.D., Strahan, K.M., Preece, A.F., Gustafsson, K., Cosset, F-L., Weiss, R.A., and Colins, M.K.L., 1996, Sensitization of cells and retroviruses to human serum by (α-1–3)galactosyltransferase. Nature 379: 85–88.
Thall, A.D., Maly, P., and Lowe, J.B., 1995, Oocyte gal-α-1,3gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem. 270: 21437–21440.
Towbin, H., Rosenfelder, G., Wieslander, J., Avila, J.L., Rojas, M., Szarfman, K., Esser, K., Nowack, H., and Timpl, R., 1987, Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(α-1–3)galactose epitopes. J. Exp. Med. 166: 419–432.
Unterkircher, C., Avrameas, S., and Ternynck, T., 1993, Autoantibodies in the sera of Trypanosoma cruzi-infected individuals with or without clinical Chagas’ disease. J. Clin. Laborat. Anal. 7: 60–69.
Van der Rijn, I., Zabriskie, J.B., and McCarty, M., 1977, Group A streptococcal antigens cross-reactive with myocardium: purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J. Exp. Med. 146: 579–599.
Van Voorhis, W.C., Schlekewy, L., and Trong, H.L., 1991, Molecular mimicry by Trypanosoma cruzi: The Fl-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc. Natl. Acad. Sci.USA. 88: 5993–5997.
WHO, 1995, Twelfth Programme Report of the UNDP/World Bank/WHO Special Programme for research and training in tropical diseases. In WHO-Tropical Diseases Research, World Health Organization, Geneva, p. 12
Winter, G., Fuchs, M., McConville, M.J., Stierhof. Y-D., and Overath, P., 1994, Surface antigens of Leishmania mexicana amastigotes: characterization of glycoinositol phospholipids and a macrophage-derived glycosphingolipid. J. Cell. Sci. 107: 2471–2482.
Wolff, P.G., Kuhl, U., and Schultheiss, H-P., 1989, Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am. Heart J. 117: 1303–1309.
Wood, C., Kabat, E.A., Murphy, L.A., and Goldstein, I.J., 1979, Inmunochemical studies on the combining sites of two isolectins A4 and B4 isolated from Bandeiraea simplicifolia. Arch. Biochem. Biophys. 198: 1–8.
Zamze, S.E., Ashford, D.A., Wooten, E.W., Rademacher, T.W., and Dwek, R.A., 1991, Structural characterization of the asparagine-linked oligosaccharides from Trypanosoma brucei type II and III variant surface glycoproteins. J. Biol. Chem. 266: 20244–20261.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Avila, J.L. (1999). α-Galactosyl-Bearing Epitopes as Potent Immunogens in Chagas’ Disease and Leishmaniasis. In: Galili, U., Avila, J.L. (eds) α-Gal and Anti-Gal. Subcellular Biochemistry, vol 32. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4771-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4771-6_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7160-1
Online ISBN: 978-1-4615-4771-6
eBook Packages: Springer Book Archive